The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
In this short webcast, Dena Jackson and Sophie Rutherford discuss connecting the organization to the supply chain department in order to build coll
Podcasts
Teresa Dail, AHRMM’s 2018 Chair, shares AHRMM’s definition of clinical integration and why a clinically integrated supply chain is important to her
Podcasts
Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician con
Podcasts
Jake Crampton, chief executive officer, Medspeed discusses intra-company logistics, which is a relatively new concept that is all about leveraging
Podcasts
Join Karen Conway, Vice President of Healthcare Value at GHX and Mike Schiller, Vice President of Healthcare Engagement at SteriTrack for a convers
Podcasts
David Reed, Vice President Healthcare Solutions, Cook Medical, discusses the generational gap in health care supply chain leadership as health care